| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human RAP1 GTPase activating protein (RAP1GAP), transcript variant 3 from ORIGENE TECHNOLOGIES | TP308271 | 20 ug | ORIGENE TECHNOLOGIES |
| Human RAP1, GTP-GDP dissociation stimulator 1 (RAP1GDS1), transcript variant 2 from ORIGENE TECHNOLOGIES | TP300924 | 20 ug | ORIGENE TECHNOLOGIES |
| Human RAP1, GTP-GDP dissociation stimulator 1 (RAP1GDS1), transcript variant 3 from ORIGENE TECHNOLOGIES | TP312781 | 20 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561689 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561729 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561630 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561783 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561784 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561864 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561868 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561831 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561874 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561876 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561982 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR561998 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562000 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562033 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562110 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562095 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562152 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562187 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562207 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562212 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562220 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562237 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562244 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562252 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562267 | 5 ug | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, ductal, solid from ORIGENE TECHNOLOGIES | CS807395 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, ductal, solid from ORIGENE TECHNOLOGIES | CS524919 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, ductal, solid from ORIGENE TECHNOLOGIES | CS529455 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, ductal, solid from ORIGENE TECHNOLOGIES | CS530884 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, lobular from ORIGENE TECHNOLOGIES | CS700744 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, lobular from ORIGENE TECHNOLOGIES | CS801723 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, lobular from ORIGENE TECHNOLOGIES | CS712832 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, lobular from ORIGENE TECHNOLOGIES | CS513595 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, lobular from ORIGENE TECHNOLOGIES | CS516503 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, lobular from ORIGENE TECHNOLOGIES | CS517616 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, lobular from ORIGENE TECHNOLOGIES | CS605595 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma in situ of breast, papillary from ORIGENE TECHNOLOGIES | CS812045 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma of breast from ORIGENE TECHNOLOGIES | CS531033 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma of breast, papillary from ORIGENE TECHNOLOGIES | CS709685 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Carcinoma of breast, squamous cell from ORIGENE TECHNOLOGIES | CS532986 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Chemotherapy effect from ORIGENE TECHNOLOGIES | CS515517 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal ectasia of breast from ORIGENE TECHNOLOGIES | CS626735 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS704771 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS704772 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS704778 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS708618 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CS716623 | 5x5um | ORIGENE TECHNOLOGIES |